XENE·98420N105·US·equity·Healthcare - Biotechnology-13D/G
XENE (XENON PHARMACEUTICALS INC) is held by 148 institutional investors as of Q1 2026. Largest holders: FMR LLC ($629.1M), Avoro Capital Advisors LLC ($336M), BlackRock, Inc. ($328M). Net institutional sentiment: Bullish.
See how XENE's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer